Instituto Ceos Site Number : 0760021

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• COPD2 trials

Phase

• Phase 32 trials

Status

• Completed2 trials

Lead sponsor

• Sanofi2 trials

Closed trials

• Completed

  A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD

  NCT06208306· Phase 3· Sanofi· Source

• Completed

  Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)

  NCT04751487· Phase 3· Sanofi· Source